Realtek Denied $1.5M In Fees For Semiconductor Patent Suit

Wednesday, April 1, 2026iiplaeditorialSource: IIPLA
realtek-denied-1-5m-in-fees-for-semicond.png
Source attribution
Image: Image courtesy of iipla.org

Realtek Denied $1.5M In Fees For Semiconductor Patent Suit

By Editorial Team

A Texas federal judge has denied Realtek Semiconductor Corp.'s request for $1.5 million in attorney fees despite it being a prevailing party in a patent infringement suit. The judge stated that the accusing company's agreement with a Realtek rival to sue Realtek for $1 million did not make the case "exceptional" enough for the legal fees.

The case involved a semiconductor patent suit where Realtek was the prevailing party. However, the judge found that the circumstances surrounding the case did not warrant the award of attorney fees to Realtek.

Realtek had sought $1.5 million in attorney fees, but the judge ruled against this request, citing the agreement between the accusing company and a Realtek rival as a key factor in the decision.

Despite being successful in the patent infringement suit, Realtek will not receive the requested attorney fees, as the judge did not find the case to be "exceptional" under the circumstances.

The case sheds light on the complexities of attorney fee awards in patent infringement suits and the factors that courts consider when making such decisions.

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026